Maulik Vyas

Marburg An Der Lahn, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Corrigendum to 'Health networking on cancer in the European Union: a 'green paper' by the EU Joint Action on Networks of Expertise (JANE)': [ESMO Open. Volume 10, Issue 2, February 2025, 104126].

Corrigendum to 'Health networking on cancer in the European Union: a 'green paper' by the EU Joint Action on Networks of Expertise (JANE)': [ESMO Open. Volume 10, Issue 2, February 2025, 104126].

Journal: ESMO open

Published: August 05, 2026

Health networking on cancer in the European Union: a 'green paper' by the EU Joint Action on Networks of Expertise (JANE).

Health networking on cancer in the European Union: a 'green paper' by the EU Joint Action on Networks of Expertise (JANE).

Journal: ESMO open

Published: September 02, 2024

Natural killer cells suppress cancer metastasis by eliminating circulating cancer cells.

Natural killer cells suppress cancer metastasis by eliminating circulating cancer cells.

Journal: Frontiers in immunology

Published: November 14, 2022

Extracellular matrix-natural killer cell interactome: an uncharted territory in health and disease.

Extracellular matrix-natural killer cell interactome: an uncharted territory in health and disease.

Journal: Current opinion in immunology

Published: August 17, 2022

The extracellular matrix and immunity: breaking the old barrier in cancer.

The extracellular matrix and immunity: breaking the old barrier in cancer.

Journal: Trends in immunology

Published: April 20, 2022

Extracellular matrix proteins regulate NK cell function in peripheral tissues.

Extracellular matrix proteins regulate NK cell function in peripheral tissues.

Journal: Science advances

Published: March 16, 2022

Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset.

Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset.

Journal: Frontiers in immunology

Published: September 17, 2018

Soluble NKG2D ligands in the ovarian cancer microenvironment are associated with an adverse clinical outcome and decreased memory effector T cells independent of NKG2D downregulation.

Soluble NKG2D ligands in the ovarian cancer microenvironment are associated with an adverse clinical outcome and decreased memory effector T cells independent of NKG2D downregulation.

Journal: Oncoimmunology

Published: March 08, 2017

Kinesin-5 Blocker Monastrol Protects Against Bortezomib-Induced Peripheral Neurotoxicity.

Kinesin-5 Blocker Monastrol Protects Against Bortezomib-Induced Peripheral Neurotoxicity.

Journal: Neurotoxicity research

Published: March 06, 2017

Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset.

Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset.

Journal: Frontiers in immunology

Published: February 24, 2017

Antigen Loss Variants: Catching Hold of Escaping Foes.

Antigen Loss Variants: Catching Hold of Escaping Foes.

Journal: Frontiers in immunology

Published: January 04, 2017

Mono- and dual-targeting triplebodies activate natural killer cells and have anti-tumor activity in vitro and in vivo against chronic lymphocytic leukemia.

Mono- and dual-targeting triplebodies activate natural killer cells and have anti-tumor activity in vitro and in vivo against chronic lymphocytic leukemia.

Journal: Oncoimmunology

Published: May 04, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026